23
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Oestradiol-17β Increases the Firing Rate of Antidromically Identified Neurones of the Rat Neostriatum

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Extracellular recordings were made from the neostriatum of rats anaesthetised with halothane. Normal male and female animals were used as well as castrated animals with implants containing oestradiol-17β (E<sub>2</sub>). In animals with high levels of circulating oestrogen, intact pro-oestrous rats and females and males bearing an E2 implant, individual units could be recorded that were spontaneously active and with axons that could be excited by stimulation in the crus cerebri. Such antidromically identified striato-nigral neurones were invariably silent in male animals and in ovariectomised females. In contrast to animals in pro-oestrus, intact female animals during metoestrus showed the ‘male’ pattern of striatal cell activity. These results show that E<sub>2</sub> can stimulate spontaneous firing of striato-nigral neurons, and that this action of E2 is not sex-dependent.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1983
          1983
          27 March 2008
          : 37
          : 2
          : 106-110
          Affiliations
          MRC Brain Metabolism Unit, Department of Pharmacology, Edinburgh, UK
          Article
          123527 Neuroendocrinology 1983;37:106–110
          10.1159/000123527
          6684218
          90db9734-ab8e-41ae-838e-b34d40717df8
          © 1983 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 5
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Estradiol-17β,Striato-nigral cells,Neostriatal cells,Cortico-striatal activation

          Comments

          Comment on this article